Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
08/2002
08/07/2002EP1228039A1 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
08/07/2002EP1227722A1 Novel succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections
08/07/2002EP1107949A4 Process for preparing certain phenyl urea compounds
08/07/2002EP0839143B1 Tetralin compounds with mdr activity
08/07/2002EP0801649B1 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
08/07/2002EP0770599B1 Process for the preparation of aromatic or heteroaromatic sulfonyl halides
08/07/2002EP0638112B1 Liquid crystal compounds having perfluoroether terminal portions
08/07/2002CN1362959A C10 carbamoyloxy substituted taxanes as antitumor agents
08/07/2002CN1362958A C7 carbonate substituted taxanes as antitumor agents
08/07/2002CN1362951A Dihetero-substituted metalloprotease inhibitors
08/07/2002CN1362948A Process of preparing 3S-3-amino-3-acryl propionic acid and derivatives thereof
08/07/2002CN1362947A N-cyanomethylamides as protease inhibitors
08/07/2002CN1362884A Preventives/remedies for liver diseases
08/07/2002CN1088699C Preparation method for chlormethyl pyridine compound
08/06/2002US6429330 Process for producing carbocyclic nitriles
08/06/2002US6429317 Indane derivatives for antipsychotic compositions
08/06/2002US6429213 Cyclic hydroxamic acids as metalloproteinase inhibitors
08/06/2002US6429207 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
08/06/2002US6429206 Using agonist of nicotinergic acetylcholine receptors
08/06/2002US6428780 Modified amino acid
08/01/2002WO2002059215A1 Azo dyes, a process for their preparation and their use in the production of coloured plastics or polymeric colour particles, and in the dyeing or printing of hydrophobic fibre materials
08/01/2002WO2002059093A1 Methods and compositions for binding nucleic acid molecules
08/01/2002WO2002059086A1 Carboxamides as fungicides in agriculture
08/01/2002WO2002059080A2 Trisubstituted carbocyclic cyclophilin binding compounds and their use
08/01/2002WO2002059077A1 Aminoethanol derivatives
08/01/2002WO2002059074A1 Benzylamine analogue
08/01/2002WO2002058690A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
08/01/2002WO2002058658A1 Primary intermediates for oxidative coloration of hair
08/01/2002WO2002058654A1 Primary intermediates for oxidative coloration of hair
08/01/2002WO2002058653A1 Primary intermediates for oxidative coloration of hair
08/01/2002WO2002058631A2 Primary intermediates for oxidative coloration of hair
08/01/2002WO2002040431A3 Compounds having fungicidal activity and processes to make and use same
08/01/2002WO2002012190A3 Non-imidazole aryloxypiperidines as h3 receptor ligands
08/01/2002WO2002008190A3 Novel heteroaryl derivatives and use thereof as anti-tumour agents
08/01/2002US20020103387 Compounds which mimic the chemical and biological properties of discodermolide
08/01/2002US20020103379 Making 2,2-difluoro-2-(2-pyridyl)-ethan-1-ol, by coupling 2-bromopyridine with ethyl 2-bromo-2,2-difluoroacetate, using metallic copper and solvent; chemical intermediates
08/01/2002US20020103256 Contacting helminth, nematode, insect or acarid pests or parasites or their food supply, habitat or breeding grounds with a nitroethyl derivative
08/01/2002US20020103239 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity
08/01/2002US20020103234 Heterocycl-containing carboxylic acid derivative and drug containing the same
08/01/2002US20020103228 Composition and method for use of pyridinium derivatives in cosmetic and therapeutic applications
08/01/2002US20020103227 Nitric oxide synthase inhibitors such as 6(4'-(4-phenethyl-piperazin-1-ylmethyl)-biphenyl-4-yl)-pyridin-2-ylamine for treatment and prevention of central nervous system disorders
08/01/2002US20020103217 Triphenylpropanamide compounds; useful in treating inflammations but which do not demonstrate side effects associated with other anti-inflammatory treatments such as glucocorticoids
08/01/2002US20020103203 For treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis
08/01/2002US20020103194 Secondary amine, imine, amidine, guanidine, or other nitrogen functional group compounds; for treatment or prevention of diseases in which treatment is mediated by muscarinic receptor agonism such as cognitive decline and Alzheimer's disease
08/01/2002US20020103192 Perfluoroalkylketones, ketooxazoles, ketoamides, ketoesters, and diketones, and their dihydroxy derivatives, such as 7-((1,1'-biphenyl)-3-yloxy)-1-(1,3-oxazol-2-yl)-1-heptanone
08/01/2002US20020103190 Azo amino acids derivatives
08/01/2002US20020103168 Fungicide phenylimine derivatives
08/01/2002US20020103164 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
08/01/2002US20020103071 Olefin polymerization catalyst system includes an activator, and a catalyst compound comprising a transition metal complexed with facially coordinating tridentate bisamide ligand
08/01/2002US20020102380 Ionic compounds in which the anionic load has been delocalized; ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions including polymerization
08/01/2002US20020100732 For removing metals from soils, water; pollution control; form stable, irreversible ligand-metal precipitates
08/01/2002US20020100126 Novel coupler for use in oxidative hair dyeing
08/01/2002CA2435883A1 Benzylamine analogue
08/01/2002CA2435829A1 Trisubstituted carbocyclic cyclophilin binding compounds and their use
08/01/2002CA2434311A1 4-amino-2-(1-aryloxy-ethyl)phenol compounds as primary intermediates for oxydative coloration of hair
08/01/2002CA2433819A1 Carboxamides as fungicides in agriculture
08/01/2002CA2433686A1 Primary intermediates for oxidative coloration of hair
08/01/2002CA2431611A1 Primary intermediates for oxidative coloration of hair
07/2002
07/31/2002EP1227092A2 Isonitrile intermediates for the preparation of tri-substituted imidazole compounds with multiple therapeutic properties
07/31/2002EP1227091A2 Formamide intermediates for the preparation of tri-substituted imidazole compounds with multiple therapeutic properties
07/31/2002EP1226138A1 Fab i inhibitors
07/31/2002EP1226127A2 Uracil substituted phenyl sulfamoyl carboxamides
07/31/2002EP1225955A1 Aryl olefinic azacyclic, and aryl acetylenic azacyclic compounds, pharmaceutical compositions containing them and their use as inhibitors of nicotinic cholinergic receptors
07/31/2002EP1225886A2 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
07/31/2002EP0946473B1 Fluorinated phenantrene derivatives for liquid crystal mixtures
07/31/2002EP0944565B1 1,3,5-trifluoronaphthalene derivatives for liquid crystalline mixtures
07/31/2002EP0748160B1 Process for preparing copper pyrithione
07/31/2002CN1361768A Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
07/31/2002CN1361766A Tricyclic compounds bearing acyloxymethoxy-carbonyl pendants
07/31/2002CN1361687A Phosphate transport inhibitors
07/31/2002CN1360890A Use of active retiene derivative with negative hormone and/or antagonist
07/31/2002CN1088459C 1,4-disubstituted piperazines
07/31/2002CA2369462A1 Nicotinamide acids, amides, and their mimetics active as inhibitors of pde4 isozymes
07/30/2002US6426418 Processes for the manufacturing of 3-hydroxy-N,1,6-trialkyl-4-oxo-1,4-dihydropyridine-2-carboxamide
07/30/2002US6426366 Pharmaceutical compositions comprising tyrphostins
07/30/2002US6426365 CETP activity inhibitors
07/30/2002US6426354 Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme
07/30/2002US6426349 Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes for neoplasia
07/30/2002US6426348 For therapy of inflammation associated with chronic inflammatory diseases such as rheumatoid arthritis (ra), multiple sclerosis, (ms), asthma, and inflammatory bowel disease (i bd)
07/30/2002US6426346 Anticoagulants
07/25/2002WO2002057492A1 Methods and compositions for detecting polynucleotide duplex damage
07/25/2002WO2002057422A2 Ternary biomolecule/polymer/surface-based immobilization systems
07/25/2002WO2002057370A1 Dispers-reactive dyes containing acetoxymethylsulfone or vinylsulfone and their process
07/25/2002WO2002057242A2 Urea derivatives as integrin alpha 4 antagonists
07/25/2002WO2002057237A1 Hetero-tricyclic compounds having substituted amino groups
07/25/2002WO2002057236A1 Phenyl derivatives
07/25/2002WO2002057233A1 Mch antagonists and their use in the treatment of obesity
07/25/2002WO2002057220A1 Hydrazide derivatives and pharmaceutical compositions containing same
07/25/2002WO2002057219A1 Novel 1,2-diphenylethene derivatives for treatment of immune diseases
07/25/2002WO2002057216A1 Terphenyl compounds bearing substituted amino groups
07/25/2002WO2002057215A2 Sodium channel modulators
07/25/2002WO2002057211A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use
07/25/2002WO2002057199A1 Process for a homogeneously catalyzed c-c coupling reaction
07/25/2002WO2002056889A1 Method of synthesis of chromium amino acid nicotinate complex
07/25/2002WO2002056827A2 Substituted felbamate derived compounds
07/25/2002WO2002032874A3 Substituted heterocyclic compounds for treating multidrug resistance
07/25/2002WO2002032845A3 Method of producing carboxylic acid salts
07/25/2002WO2002028805A3 Process for the co-oligomerisation of ethylene and alpha olefins
07/25/2002WO2002015884A3 Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor
07/25/2002WO2002008177A3 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives